Hiroyuki Ura

Dr. Hiroyuki Ura

orcid

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2013 in Brain Research
Verified
Journal Article
Closed access
HUHiroyuki Ura
Hiroyuki Ura
YSYuki Sugaya
Yuki Sugaya
HOHisayuki Ohata
Hisayuki Ohata
ITIchiro Takumi
Ichiro Takumi
KSKiyomi Sadamoto
Kiyomi Sadamoto
EMEiichi Maru
Eiichi Maru

8 August 2024 in Epilepsy & Behavior
Verified
Journal Article
Closed access
HUHiroyuki Ura
Hiroyuki Ura
NMNoriko Matsuoka
Noriko Matsuoka
KKKiyoshi Kubota
Kiyoshi Kubota
KSKiyomi Sadamoto
Kiyomi Sadamoto

9 March 2023 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
KSKiyomi Sadamoto
Kiyomi Sadamoto
HUHiroyuki Ura
Hiroyuki Ura
MMMikio Murata
Mikio Murata
MHMasaho Hayashi
Masaho Hayashi
KKKiyoshi Kubota
Kiyoshi Kubota
Press-through packaging (PTP) is the most common type of drug packaging in Japan, and a production procedure for PTP has been established at an acceptable cost. However, unknown problems and new needs with regard to safety among users of various age-groups still need to be examined. Considering accident reports involving children and older adults, the safety and quality of PTP and new forms of PTP, such as child-resistant and senior-friendly (CRSF) packaging, should be evaluated. We conducted an ergonomic study on children and older adults to compare types of commonly used PTP and new varieties of PTP. Opening tests were attempted by children and older adults using a common type of PTP (Type A) and child-resistant (CR) PTP (Types B1 and B2) made from soft aluminum foil. The same opening test was conducted on older patients with rheumatoid arthritis (RA). The results showed that CR PTP was difficult for children to open: only 1 out of 18 children could open Type B1. On the other hand, all eight of the older adults could open Type B1, and eight patients with RA could easily open Types B1 and B2. These findings suggest that the quality of CRSF PTP can be improved with the use of new materials.

26 April 2024 in Cureus
Verified
Journal Article
Open access
HUHiroyuki Ura
Hiroyuki Ura
MSMakoto Senoo
Makoto Senoo
KKKiyoshi Kubota
Kiyoshi Kubota
KSKiyomi Sadamoto
Kiyomi Sadamoto
While the coronavirus disease 2019 (COVID-19) pandemic has impacted medication adherence and consultation patterns, its effects on the medical practice and dispensary separation system of Japan remain unclear. Thus, the utilization of the medication record handbook (MRH) in both medical and dental areas remains uncertain. This study uses the National Database of Health Insurance Claims and Specific Health Checkups of Japan (NDB); we analyzed the separation of medication prescription and dispensing in both medicine and dentistry, as well as estimated how much drug information is shared by utilizing a patientcarried MRH. The external prescription (EP) rate was used as the main indicator. We then analyzed the MRH utilization rate during outpatient medication guidance. During the pandemic, there was no distinctive change in the rate of EPs in both medicine and dentistry. Furthermore, an analysis between EPs, medical internal prescriptions (IPs), and dental IPs relative to the MRH utilization rate revealed significant correlations between EPs and medical IPs as well as medical and dental IPs. Conversely, no significant correlation was found between EPs and dental IPs. Therefore, our results suggest that active MRH implementation within healthcare facilities may lead to an increase in its utilization in dentistry.

20 March 2026 in Pharmacy
Verified
Journal Article
Open access
PDF file
HUHiroyuki Ura
Hiroyuki Ura
NMNoriko Matsuoka
Noriko Matsuoka
Preconception care is globally recognized as essential for optimizing pregnancy outcomes; however, in Japan, comprehensive data on medication-related potential exposure to pregnancy-contraindicated medications among women of reproductive age remain limited. We conducted a retrospective cross-sectional descriptive study using data from Japan’s National Database of Health Insurance Claims (fiscal year 2022) to assess the potential exposure to pregnancy-contraindicated medications among women of reproductive age. Outpatient prescriptions for oral medications dispensed to women aged 15–49 years were analyzed. In total, 270 medications classified as contraindicated during pregnancy were identified, of which 75 were also contraindicated for women planning pregnancy. Of these, 58 active ingredients were restricted in both phases. Notably, 212 medications were uniquely contraindicated during pregnancy, highlighting the broader contraindication profiles during fetal development than during the preconception period. Despite these contraindications, high prescription volumes were observed for medications such as loxoprofen sodium hydrate, sodium valproate, and metformin hydrochloride among women of reproductive age. These findings illustrate a high baseline utilization of pregnancy-contraindicated medications among women of reproductive age. As most women in this demographic are neither pregnant nor actively planning conception, these volumes primarily reflect standard care rather than inappropriate prescribing. In conclusion, pharmacists serve as an important supplementary safety net by routinely confirming pregnancy status to prevent inadvertent exposure.

1 May 2014
Verified
Journal Article
Closed access
EMEiichi Maru
Eiichi Maru
HUHiroyuki Ura
Hiroyuki Ura